Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia

被引：6
作者：
Yoshida, Nao [1 ]
Sakaguchi, Hirotoshi [1 ]
Matsumoto, Kimikazu [1 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Dept Haematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 158卷 / 05期
关键词：
gemtuzumab ozogamicin; children; refractory AML; stem cell transplantation; combination chemotherapy; VENOOCCLUSIVE DISEASE; RISK;
D O I：
10.1111/j.1365-2141.2012.09192.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 668
页数：3
相关论文
共 50 条
  • [21] T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia
    Sano, Hideki
    Mochizuki, Kazuhiro
    Kobayashi, Shogo
    Ohara, Yoshihiro
    Ito, Masaki
    Waragai, Tomoko
    Takahashi, Nobuhisa
    Ikeda, Kazuhiko
    Ohto, Hitoshi
    Kikuta, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (01) : 76 - 84
  • [22] T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia
    Hideki Sano
    Kazuhiro Mochizuki
    Shogo Kobayashi
    Yoshihiro Ohara
    Masaki Ito
    Tomoko Waragai
    Nobuhisa Takahashi
    Kazuhiko Ikeda
    Hitoshi Ohto
    Atsushi Kikuta
    International Journal of Hematology, 2018, 108 : 76 - 84
  • [23] Low-dose decitabine for refractory thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children: A pilot study
    Liu, Nan
    Zhao, Fen-Ying
    Liang, Juan
    Shang, Li-Ping
    Xu, Xiao-Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [24] Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)
    Amadori, Sergio
    Suciu, Stefan
    Selleslag, Dominik
    Stasi, Roberto
    Alimena, Giuliana
    Baila, Liliana
    Rizzoli, Vittorio
    Borlenghi, Erika
    Gaidano, Gianluca
    Magro, Domenico
    Torelli, Giuseppe
    Muus, Petra
    Venditti, Adriano
    Cacciola, Emma
    Lauria, Francesco
    Vignetti, Marco
    de Witte, Theo
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) : 376 - 382
  • [25] Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid
    Vincenza Martini
    Clara Minotti
    Massimo Breccia
    Gioia De Angelis
    Sonia Buffolino
    Montano Mariella
    Francesco Lo-Coco
    Giuseppe Avvisati
    Giuseppe Cimino
    Annals of Hematology, 2007, 86 : 295 - 297
  • [26] Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial
    Burnett, Alan
    Cavenagh, Jamie
    Russell, Nigel
    Hills, Robert
    Kell, Jonathan
    Jones, Gail
    Nielsen, Ove Juul
    Khwaja, Asim
    Thomas, Ian
    Clark, Richard
    HAEMATOLOGICA, 2016, 101 (06) : 724 - 731
  • [27] HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI
    Willemze, A. J.
    Geskus, R. B.
    Noordijk, E. M.
    Kal, H. B.
    Egeler, R. M.
    Vossen, J. M.
    BONE MARROW TRANSPLANTATION, 2007, 40 (04) : 319 - 327
  • [28] HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI
    A J Willemze
    R B Geskus
    E M Noordijk
    H B Kal
    R M Egeler
    J M Vossen
    Bone Marrow Transplantation, 2007, 40 : 319 - 327
  • [29] Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab
    Ma, Wanlu
    Bai, Wei
    Wu, Xueyan
    Zhao, Jiuliang
    Li, Mengtao
    Zeng, Xiaofeng
    LUPUS, 2020, 29 (14) : 1961 - 1967
  • [30] Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT
    Battipaglia, G.
    Labopin, M.
    Candoni, A.
    Fanin, R.
    El Cheikh, J.
    Blaise, D.
    Michallet, M.
    Ruggeri, A.
    Contentin, N.
    Ribera, J. M.
    Stadler, M.
    Sierra, J.
    Borne, P. A. von Dem
    Bloor, A.
    Socie, G.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 (04) : 592 - 599
12345